Policyholder Services

Will OMIC cover me for the intravitreal injection of kenalog?

Yes. Although the use of Kenalog has been FDA approved only for intramuscular administration, intra-articular administration, and administration within a tendon sheath, this steroid is routinely used on an off-label basis by ophthalmologists. Provided that the indication of the injection (whether subconjunctivally, subTenon, into the lid, or intravitreally) is appropriate and the physician is properly trained and experienced, OMIC will extend coverage for the insured’s use of Kenalog.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment

Six reasons OMIC is the best choice for ophthalmologists in America.

Expertise unmatched.

OMIC's sole mission is to serve ophthalmology. The premier source of ophthalmic claims data and loss prevention materials, OMIC's member hotline is the most used ophthalmic consultative service of its kind and OMIC.com is the most visited web site in America for ophthalmic risk management advice and patient consent documents.